<DOC>
	<DOCNO>NCT00000698</DOCNO>
	<brief_summary>To determine safety effectiveness intravenous ganciclovir ( also know DHPG ) treatment sight-threatening cytomegalovirus ( CMV ) retinitis patient AIDS . CMV retinitis severe vision-threatening viral infection retina eye . It occur patient whose immune function impair common cause blindness patient AIDS . Ganciclovir ( GCV ) improve sign symptom CMV retinitis approximately 80 percent patient treat 2 week , almost patient treat GCV relapse treatment stop . Thus , important determine GCV safely give long period time ( maintenance therapy ) effective prevent relapse CMV retinitis .</brief_summary>
	<brief_title>A Treatment Protocol Use Intravenous Ganciclovir AIDS Patients With Immediately Sight-Threatening CMV Retinitis</brief_title>
	<detailed_description>CMV retinitis severe vision-threatening viral infection retina eye . It occur patient whose immune function impair common cause blindness patient AIDS . Ganciclovir ( GCV ) improve sign symptom CMV retinitis approximately 80 percent patient treat 2 week , almost patient treat GCV relapse treatment stop . Thus , important determine GCV safely give long period time ( maintenance therapy ) effective prevent relapse CMV retinitis . Patients give GCV intravenously 14 day . Then patient receives dose , day , long therapy tolerate . If retinitis worsen maintenance phase , patient may give GCV 14 day . Long-term treatment GCV usually require surgical placement catheter large central vein chest groin leave place indefinitely . If require , procedure explain patient .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Aerosolized pentamidine prophylaxis Pneumocystis carinii pneumonia . Topical ophthalmics . Topical acyclovir . Concurrent Treatment : Allowed : Hemodialysis patient renal impairment . Patients must : Diagnosis AIDS immediately sightthreatening cytomegalovirus retinitis . Prior Medication : Allowed : Zidovudine . Prior therapy retinitis . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Nonimmediately sightthreatening cytomegalovirus retinitis . Concurrent Medication : Excluded : Systemic investigational agent antimetabolite , alkylating agent , nucleoside analog , acyclovir sodium ( Zovirax ) . Interferon . Cytokines . Foscarnet ( nonnucleoside pyrophosphate analog ) . Ganciclovir may withhold 21 day acute course investigational toxic therapy oral / IV acyclovir . Patients follow exclude : Nonimmediately sightthreatening cytomegalovirus retinitis .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1992</verification_date>
	<keyword>Retinitis</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>